Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Multi-omics Market: By Type, By Platform, By Indication, and By Region Forecast 2020-2031, and Forecast to 2030.
The global multi-omics market was valued at US$ 2,619.5 million in 2024 and is expected to reach US$ 5,974.3 million by 2030, at a CAGR of 12.5% during the forecast period 2024 – 2030. The multi-omics market refers to the sector within biotechnology and bioinformatics that involves the integration and analysis of multiple "omics" data types, such as genomics, proteomics, metabolomics, transcriptomics, and epigenomics. These approaches allow researchers to gain a comprehensive understanding of biological systems by studying various molecular levels simultaneously. The market growth can be attributed to the increasing demand for single-cell multi-omics and advancements in omics technologies. Moreover, the categories, such as genomics, proteomics, metabolomics, and transcriptomics are gaining momentum for healthcare purposes. The COVID-19 pandemic had a positive impact on the industry. The multi-omics approaches have been considered for COVID-19 diagnosis and insights. Various studies and research were conducted to understand the multi-omics role in the COVID-19 diagnosis. For instance, according to the study published by the MDPI in September 2021, multi-omics technology can provide significant new insights to understand COVID-19. Additionally, the emphasis on personalized medicine encourages healthcare providers and researchers to utilize multi-omics technologies to a greater extent. Sharing data is crucial for advancing collaborative multi-omics research but concerns about patient privacy and regulatory compliance can impose limits. This might impede research collaboration and limit access to multi-omics datasets. Regulatory shifts can occur unexpectedly and frequently, necessitating constant monitoring and adaptation by market players. This dynamic environment introduces uncertainty into their operations.
Recent Developments of the Market:
Study Period
2025-2031Base Year
2024CAGR
12.5%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
Advanced omics technologies with high-throughput capabilities have significantly lowered the expenses associated with data generation. This cost reduction has made multi-omics research more accessible to a broader spectrum of researchers, institutions, and businesses. Consequently, there's a surge in market participants, which stimulates innovation and competitiveness. This detailed approach is essential for pinpointing potential biomarkers and therapeutic targets. The decreased entry barriers have nurtured a flourishing landscape of start-ups and firms focusing on omics technologies and services. These dynamics are projected to drive future demand. Multi-omics data can provide a detailed understanding of a patient's genetic predispositions, biomarker profiles, and disease risks. This integration boosts the demand for multi-omics technologies and services. The demand for these data in personalized medicine has created opportunities for innovative start-ups and established companies to provide specialized services and technologies. Thus, these factors will drive the expansion of the market in the upcoming years.
Report Benchmarks |
Details |
Report Study Period |
2025-2031 |
Market Size in 2030 |
US$ 5,974.3 million |
Market CAGR |
12.5% |
By Type |
|
By Indication |
|
By Platform |
|
Download Free Sample Report
The global multi-omics market was valued at US$ 2,619.5 million in 2024 and is expected to reach US$ 5,974.3 million by 2030, at a CAGR of 12.5% during the forecast period 2024 – 2030.
The leading players in the multi-omics market are Thermo Fisher Scientific Inc., Illumina, Inc., PerkinElmer Inc., Shimadzu Corporation, Bruker, Agilent Technologies, Inc., Qiagen N.V., Bio-Rad Laboratories Inc., Waters Corporation, Roche Holding AG, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Eurofins Scientific, and BGI Group.
“North America” had the largest share in the multiomics market.
The major driver for the multiomics market is high demand in pharmaceuticals.
1. Executive Summary |
2. Global Multi-omics Market Introduction |
2.1.Global Multi-omics Market - Taxonomy |
2.2.Global Multi-omics Market - Definitions |
2.2.1.Type |
2.2.2.Indication |
2.2.3.Platform |
2.2.4.Region |
3. Global Multi-omics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Multi-omics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Multi-omics Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Single-cell multi-omics |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Bulk multi-omics |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Multi-omics Market By Indication, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Cell Biology |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Oncology |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Neurology |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Immunology |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Multi-omics Market By Platform, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Genomics |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Transcriptomics |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Proteomics |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Metabolomics |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Integrated Omics Platforms |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. Global Multi-omics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Multi-omics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Single-cell multi-omics |
9.1.2.Bulk multi-omics |
9.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Cell Biology |
9.2.2.Oncology |
9.2.3.Neurology |
9.2.4.Immunology |
9.3. Platform Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Genomics |
9.3.2.Transcriptomics |
9.3.3.Proteomics |
9.3.4.Metabolomics |
9.3.5.Integrated Omics Platforms |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Multi-omics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Single-cell multi-omics |
10.1.2.Bulk multi-omics |
10.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Cell Biology |
10.2.2.Oncology |
10.2.3.Neurology |
10.2.4.Immunology |
10.3. Platform Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Genomics |
10.3.2.Transcriptomics |
10.3.3.Proteomics |
10.3.4.Metabolomics |
10.3.5.Integrated Omics Platforms |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Multi-omics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Single-cell multi-omics |
11.1.2.Bulk multi-omics |
11.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Cell Biology |
11.2.2.Oncology |
11.2.3.Neurology |
11.2.4.Immunology |
11.3. Platform Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Genomics |
11.3.2.Transcriptomics |
11.3.3.Proteomics |
11.3.4.Metabolomics |
11.3.5.Integrated Omics Platforms |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Multi-omics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Single-cell multi-omics |
12.1.2.Bulk multi-omics |
12.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Cell Biology |
12.2.2.Oncology |
12.2.3.Neurology |
12.2.4.Immunology |
12.3. Platform Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Genomics |
12.3.2.Transcriptomics |
12.3.3.Proteomics |
12.3.4.Metabolomics |
12.3.5.Integrated Omics Platforms |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Multi-omics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Single-cell multi-omics |
13.1.2.Bulk multi-omics |
13.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Cell Biology |
13.2.2.Oncology |
13.2.3.Neurology |
13.2.4.Immunology |
13.3. Platform Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Genomics |
13.3.2.Transcriptomics |
13.3.3.Proteomics |
13.3.4.Metabolomics |
13.3.5.Integrated Omics Platforms |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Thermo Fisher Scientific Inc. |
14.2.2.Illumina, Inc. |
14.2.3.PerkinElmer Inc. |
14.2.4.Shimadzu Corporation |
14.2.5.Bruker |
14.2.6.Agilent Technologies, Inc. |
14.2.7.Qiagen N.V. |
14.2.8.Bio-Rad Laboratories Inc. |
14.2.9.Waters Corporation |
14.2.10.Roche Holding AG |
14.2.11.Oxford Nanopore Technologies Ltd. |
14.2.12.Pacific Biosciences of California Inc. |
14.2.13.Eurofins Scientific |
14.2.14.BGI Group |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players